Predicine

Predicine is a molecular information company that develops genomic profiling tests and robust algorithms for cancer diagnosis and monitoring. A biology-driven approach to analyzing genomics is advancing the understanding of the tumor mutational landscape. The company offers a 600-gene panel to facilitate biomarker-driven patient enrollment in clinical trials. Predicine's biology-driven genomic analysis approach is enhancing the understanding of the tumor mutational landscape. With its extensive dataset and advanced analytics, Predicine collaborates with over 30 biopharmaceutical companies, supporting their clinical trials in the United States, European Union, Australia, and China.